ATE213334T1 - Vorgeburtliche überprüfung von schwangerschaftsabnormitäten - Google Patents
Vorgeburtliche überprüfung von schwangerschaftsabnormitätenInfo
- Publication number
- ATE213334T1 ATE213334T1 AT95305618T AT95305618T ATE213334T1 AT E213334 T1 ATE213334 T1 AT E213334T1 AT 95305618 T AT95305618 T AT 95305618T AT 95305618 T AT95305618 T AT 95305618T AT E213334 T1 ATE213334 T1 AT E213334T1
- Authority
- AT
- Austria
- Prior art keywords
- marker
- level
- pregnancy
- woman
- abnormities
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/385—Congenital anomalies
- G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Data Mining & Analysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Databases & Information Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
- Fire Alarms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9416415A GB9416415D0 (en) | 1994-08-13 | 1994-08-13 | Antenatel screening for pregnacy abnormalities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213334T1 true ATE213334T1 (de) | 2002-02-15 |
Family
ID=10759858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95305618T ATE213334T1 (de) | 1994-08-13 | 1995-08-11 | Vorgeburtliche überprüfung von schwangerschaftsabnormitäten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6022695A (de) |
| EP (1) | EP0701131B1 (de) |
| JP (1) | JP3626251B2 (de) |
| KR (1) | KR100389988B1 (de) |
| AT (1) | ATE213334T1 (de) |
| AU (1) | AU698204B2 (de) |
| CA (1) | CA2155919C (de) |
| DE (1) | DE69525400T2 (de) |
| FI (1) | FI119451B (de) |
| GB (1) | GB9416415D0 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606261D0 (en) * | 1996-03-25 | 1996-05-29 | Johnson & Johnson Clin Diag | Prenatal screening for fetal abnormalities |
| GB9614615D0 (en) * | 1996-07-11 | 1996-09-04 | Isis Innovation | Diagnosis of pre-eclampsia |
| US6620590B2 (en) | 1996-07-11 | 2003-09-16 | Isis Innovation Limited | Diagnosis of pre-eclampsia |
| WO2003098388A2 (en) * | 2002-05-15 | 2003-11-27 | U.S. Government, As Represented By The Secretary Of The Army | System and method for handling medical information |
| US20050131738A1 (en) * | 2002-05-15 | 2005-06-16 | Morris Tommy J. | System and method for handling medical information |
| US7315787B2 (en) * | 2003-10-07 | 2008-01-01 | Ntd Laboratories, Inc. | Multi-marker screening protocol for fetal abnormalities |
| EP1691665A4 (de) * | 2003-12-02 | 2009-10-28 | Shraga Rottem | Künstliche intelligenz und vorrichtung zur diagnose, screening, prävention und behandlung von maternofötalen zuständen |
| EP1716419A2 (de) * | 2004-02-20 | 2006-11-02 | AplaGen GmbH | Verfahren zum nachweis von autoantikörpern gegen spezifische peptide und dessen verwendung bei der diagnose und behandlung von schwangerschaftsverlust oder unfruchtbarkeit |
| US20100285974A1 (en) * | 2007-07-02 | 2010-11-11 | The University Court Of The University Of Edinburg | Identification of ectopic pregnancies |
| US20100027571A1 (en) * | 2008-07-31 | 2010-02-04 | Murdoch Keith M | Stabilized near-infrared laser |
| WO2011144999A1 (en) | 2010-05-17 | 2011-11-24 | Sandra Reznik | Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities |
| CN116358954B (zh) * | 2023-02-22 | 2024-08-09 | 深圳市昭蓝生物科技有限公司 | 复合质控品及其制备方法和产前筛查试剂盒 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874693A (en) * | 1986-10-10 | 1989-10-17 | Mark Bogart | Method for assessing placental dysfunction |
| EP0362294B1 (de) * | 1987-07-09 | 1993-06-30 | 3i RESEARCH EXPLOITATION LIMITED | Pränatales screening für downs-syndrom |
| GB8816714D0 (en) * | 1988-07-14 | 1988-08-17 | Univ Court Of University Of Gl | Switched reluctance motors |
| ATE252240T1 (de) * | 1989-01-17 | 2003-11-15 | Jn Macri Technologies Llc Inc | Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes |
| GB9224965D0 (en) * | 1992-11-28 | 1993-01-20 | Kodak Ltd | Antenatal screening for chromosomal abnormalities |
| GB9410345D0 (en) * | 1994-05-24 | 1994-07-13 | Univ Oxford Brookes | Method of genetic testing |
| US5716853A (en) * | 1995-07-07 | 1998-02-10 | Chiron Diagnostics Corporation | Prenatal down syndrome screening with assays specific for UGP |
-
1994
- 1994-08-13 GB GB9416415A patent/GB9416415D0/en active Pending
-
1995
- 1995-08-07 US US08/511,942 patent/US6022695A/en not_active Expired - Lifetime
- 1995-08-10 AU AU28487/95A patent/AU698204B2/en not_active Expired
- 1995-08-11 DE DE69525400T patent/DE69525400T2/de not_active Expired - Lifetime
- 1995-08-11 JP JP20583995A patent/JP3626251B2/ja not_active Expired - Fee Related
- 1995-08-11 AT AT95305618T patent/ATE213334T1/de not_active IP Right Cessation
- 1995-08-11 CA CA002155919A patent/CA2155919C/en not_active Expired - Lifetime
- 1995-08-11 FI FI953830A patent/FI119451B/fi not_active IP Right Cessation
- 1995-08-11 EP EP95305618A patent/EP0701131B1/de not_active Expired - Lifetime
- 1995-08-14 KR KR1019950024989A patent/KR100389988B1/ko not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2155919C (en) | 2007-06-05 |
| JPH09113508A (ja) | 1997-05-02 |
| AU2848795A (en) | 1996-02-29 |
| US6022695A (en) | 2000-02-08 |
| EP0701131A2 (de) | 1996-03-13 |
| CA2155919A1 (en) | 1996-02-14 |
| AU698204B2 (en) | 1998-10-29 |
| EP0701131A3 (de) | 1996-05-29 |
| GB9416415D0 (en) | 1994-10-05 |
| FI953830A0 (fi) | 1995-08-11 |
| FI119451B (fi) | 2008-11-14 |
| KR960008312A (ko) | 1996-03-22 |
| KR100389988B1 (ko) | 2003-12-06 |
| DE69525400T2 (de) | 2002-07-18 |
| FI953830L (fi) | 1996-02-14 |
| DE69525400D1 (de) | 2002-03-21 |
| EP0701131B1 (de) | 2002-02-13 |
| JP3626251B2 (ja) | 2005-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE213334T1 (de) | Vorgeburtliche überprüfung von schwangerschaftsabnormitäten | |
| ES2262319T3 (es) | Cribado prenatal para sindrome de down. | |
| Haddow et al. | Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. | |
| DE69328169D1 (de) | Prüfung vor der geburt für abnormitäten der chromosomen | |
| CA2121680A1 (en) | Screening method for identifying women at increased risk for preterm delivery | |
| DE69739072D1 (de) | Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin | |
| ATE227024T1 (de) | Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut | |
| DE3882140D1 (en) | Praenatales screening fuer downs-syndrom. | |
| Zeitune et al. | Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha fetoprotein and age: A retrospective study of 142 pregnancies | |
| SMITH et al. | Interpretation of in‐vitro thyroid function tests during pregnancy | |
| DE69418759D1 (de) | Vorgeburtliche Überprüfung von Missbildungen der Chromosomen | |
| Loncar et al. | Advent of maternal serum markers for Down syndrome screening | |
| Canini et al. | Comparison of First Trimester, Second Trimester and Integrated Downs Syndrome Screening Results in Unaffected Pregnancies | |
| DE69418654D1 (de) | Vorgeburtliche Überprüfung von Missbildungen der Chromosomen | |
| DE69721889D1 (de) | Pränatales Testverfahren für Down-Syndrom | |
| Easterling et al. | Maternal weight, hemodynamics, and preeclampsia | |
| Petrikovsky | Procedural risks versus theology: Chorionic villus sampling for Orthodox Jews at less than 8 weeks' gestation | |
| Chodirker | Maternal serum screening: What do the results mean? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |